1. PrusinerSB (1982) Novel proteinaceous infectious particles cause scrapie. Science 216: 136–144.
2. JarrettJT, LansburyPTJr (1993) Seeding “one-dimensional crystallization” of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? Cell 73: 1055–1058.
3. PanKM, BaldwinM, NguyenJ, GassetM, SerbanA, et al. (1993) Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci U S A 90: 10962–10966.
4. SailerA, BuelerH, FischerM, AguzziA, WeissmannC (1994) No propagation of prions in mice devoid of PrP. Cell 77: 967–968.
5. CaugheyB, KociskoDA, RaymondGJ, LansburyPTJr (1995) Aggregates of scrapie-associated prion protein induce the cell-free conversion of protease-sensitive prion protein to the protease-resistant state. Chem Biol 2: 807–817.
6. BeekesM, McBridePA, BaldaufE (1998) Cerebral targeting indicates vagal spread of infection in hamsters fed with scrapie. J Gen Virol 79(Pt 3): 601–607.
7. KimberlinRH, WalkerCA (1982) Pathogenesis of mouse scrapie: patterns of agent replication in different parts of the CNS following intraperitoneal infection. J R Soc Med 75: 618–624.
8. WicknerRB (1994) [URE3] as an altered URE2 protein: evidence for a prion analog in Saccharomyces cerevisiae. Science 264: 566–569.
9. GloverJR, KowalAS, SchirmerEC, PatinoMM, LiuJJ, et al. (1997) Self-seeded fibers formed by Sup35, the protein determinant of [PSI+], a heritable prion-like factor of S. cerevisiae. Cell 89: 811–819.
10. SerioTR, LindquistSL (1999) [PSI+]: an epigenetic modulator of translation termination efficiency. Annu Rev Cell Dev Biol 15: 661–703.
11. SerioTR, CashikarAG, KowalAS, SawickiGJ, MoslehiJJ, et al. (2000) Nucleated conformational conversion and the replication of conformational information by a prion determinant. Science 289: 1317–1321.
12. TanakaM, ChienP, NaberN, CookeR, WeissmanJS (2004) Conformational variations in an infectious protein determine prion strain differences. Nature 428: 323–328.
13. ChernoffYO, LindquistSL, OnoB, Inge-VechtomovSG, LiebmanSW (1995) Role of the chaperone protein Hsp104 in propagation of the yeast prion-like factor [psi+]. Science 268: 880–884.
14. Ter-AvanesyanMD, KushnirovVV, DagkesamanskayaAR, DidichenkoSA, ChernoffYO, et al. (1993) Deletion analysis of the SUP35 gene of the yeast Saccharomyces cerevisiae reveals two non-overlapping functional regions in the encoded protein. Mol Microbiol 7: 683–692.
15. NeumannM, KwongLK, TruaxAC, VanmassenhoveB, KretzschmarHA, et al. (2007) TDP-43-positive white matter pathology in frontotemporal lobar degeneration with ubiquitin-positive inclusions. J Neuropathol Exp Neurol 66: 177–183.
16. KwiatkowskiTJJr, BoscoDA, LeclercAL, TamrazianE, VanderburgCR, et al. (2009) Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 323: 1205–1208.
17. CushmanM, JohnsonBS, KingOD, GitlerAD, ShorterJ (2010) Prion-like disorders: blurring the divide between transmissibility and infectivity. J Cell Sci 123: 1191–1201.
18. KrammerC, SchatzlHM, VorbergI (2009) Prion-like propagation of cytosolic protein aggregates: insights from cell culture models. Prion 3: 206–212.
19. AguzziA (2009) Cell biology: Beyond the prion principle. Nature 459: 924–925.
20. SotoC (2012) Transmissible proteins: expanding the prion heresy. Cell 149: 968–977.
21. JarrettJT, LansburyPTJr (1992) Amyloid fibril formation requires a chemically discriminating nucleation event: studies of an amyloidogenic sequence from the bacterial protein OsmB. Biochemistry 31: 12345–12352.
22. HarperJD, LansburyPTJr (1997) Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. Annu Rev Biochem 66: 385–407.
23. ScherzingerE, SittlerA, SchweigerK, HeiserV, LurzR, et al. (1999) Self-assembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: implications for Huntington's disease pathology. Proc Natl Acad Sci U S A 96: 4604–4609.
24. BuschA, EngemannS, LurzR, OkazawaH, LehrachH, et al. (2003) Mutant huntingtin promotes the fibrillogenesis of wild-type huntingtin: a potential mechanism for loss of huntingtin function in Huntington's disease. J Biol Chem 278: 41452–41461.
25. KrebsMR, Morozova-RocheLA, DanielK, RobinsonCV, DobsonCM (2004) Observation of sequence specificity in the seeding of protein amyloid fibrils. Protein Sci 13: 1933–1938.
26. Meyer-LuehmannM, CoomaraswamyJ, BolmontT, KaeserS, SchaeferC, et al. (2006) Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host. Science 313: 1781–1784.
27. FrostB, JacksRL, DiamondMI (2009) Propagation of tau misfolding from the outside to the inside of a cell. J Biol Chem 284: 12845–12852.
28. DanzerKM, KrebsSK, WolffM, BirkG, HengererB (2009) Seeding induced by alpha-synuclein oligomers provides evidence for spreading of alpha-synuclein pathology. J Neurochem 111: 192–203.
29. RenPH, LaucknerJE, KachirskaiaI, HeuserJE, MelkiR, et al. (2009) Cytoplasmic penetration and persistent infection of mammalian cells by polyglutamine aggregates. Nat Cell Biol 11: 219–225.
30. KaneMD, LipinskiWJ, CallahanMJ, BianF, DurhamRA, et al. (2000) Evidence for seeding of beta -amyloid by intracerebral infusion of Alzheimer brain extracts in beta -amyloid precursor protein-transgenic mice. J Neurosci 20: 3606–3611.
31. MunchC, O'BrienJ, BertolottiA (2011) Prion-like propagation of mutant superoxide dismutase-1 misfolding in neuronal cells. Proc Natl Acad Sci U S A 108: 3548–3553.
32. LundmarkK, WestermarkGT, NystromS, MurphyCL, SolomonA, et al. (2002) Transmissibility of systemic amyloidosis by a prion-like mechanism. Proc Natl Acad Sci U S A 99: 6979–6984.
33. EiseleYS, ObermullerU, HeilbronnerG, BaumannF, KaeserSA, et al. (2010) Peripherally applied Abeta-containing inoculates induce cerebral beta-amyloidosis. Science 330: 980–982.
34. LiJY, EnglundE, HoltonJL, SouletD, HagellP, et al. (2008) Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation. Nat Med 14: 501–503.
35. ClavagueraF, BolmontT, CrowtherRA, AbramowskiD, FrankS, et al. (2009) Transmission and spreading of tauopathy in transgenic mouse brain. Nat Cell Biol 11: 909–913.
36. de CalignonA, PolydoroM, Suarez-CalvetM, WilliamC, AdamowiczDH, et al. (2012) Propagation of tau pathology in a model of early Alzheimer's disease. Neuron 73: 685–697.
37. LukKC, KehmVM, ZhangB, O'BrienP, TrojanowskiJQ, et al. (2012) Intracerebral inoculation of pathological alpha-synuclein initiates a rapidly progressive neurodegenerative alpha-synucleinopathy in mice. J Exp Med 209: 975–986.
38. LinkCD (1995) Expression of human beta-amyloid peptide in transgenic Caenorhabditis elegans. Proc Natl Acad Sci U S A 92: 9368–9372.
39. MorleyJF, BrignullHR, WeyersJJ, MorimotoRI (2002) The threshold for polyglutamine-expansion protein aggregation and cellular toxicity is dynamic and influenced by aging in Caenorhabditis elegans. Proc Natl Acad Sci U S A 99: 10417–10422.
40. BrignullHR, MooreFE, TangSJ, MorimotoRI (2006) Polyglutamine proteins at the pathogenic threshold display neuron-specific aggregation in a pan-neuronal Caenorhabditis elegans model. J Neurosci 26: 7597–7606.
41. GidalevitzT, KrupinskiT, GarciaS, MorimotoRI (2009) Destabilizing protein polymorphisms in the genetic background direct phenotypic expression of mutant SOD1 toxicity. PLoS Genet 5: e1000399 doi:10.1371/journal.pgen.1000399.
42. van HamTJ, ThijssenKL, BreitlingR, HofstraRM, PlasterkRH, et al. (2008) C. elegans model identifies genetic modifiers of alpha-synuclein inclusion formation during aging. PLoS Genet 4: e1000027 doi:10.1371/journal.pgen.1000027.
43. ParkKW, LiL (2008) Cytoplasmic expression of mouse prion protein causes severe toxicity in Caenorhabditis elegans. Biochem Biophys Res Commun 372: 697–702.
44. LiuJJ, LindquistS (1999) Oligopeptide-repeat expansions modulate ‘protein-only’ inheritance in yeast. Nature 400: 573–576.
45. MelendezA, TalloczyZ, SeamanM, EskelinenEL, HallDH, et al. (2003) Autophagy genes are essential for dauer development and life-span extension in C. elegans. Science 301: 1387–1391.
46. RavikumarB, ImarisioS, SarkarS, O'KaneCJ, RubinszteinDC (2008) Rab5 modulates aggregation and toxicity of mutant huntingtin through macroautophagy in cell and fly models of Huntington disease. J Cell Sci 121: 1649–1660.
47. LiuQ, ChenB, GaierE, JoshiJ, WangZW (2006) Low conductance gap junctions mediate specific electrical coupling in body-wall muscle cells of Caenorhabditis elegans. J Biol Chem 281: 7881–7889.
48. ShanerNC, SteinbachPA, TsienRY (2005) A guide to choosing fluorescent proteins. Nat Methods 2: 905–909.
49. GrantBD, SatoM (2006) Intracellular trafficking. WormBook 1–9.
50. GrantB, ZhangY, PaupardMC, LinSX, HallDH, et al. (2001) Evidence that RME-1, a conserved C. elegans EH-domain protein, functions in endocytic recycling. Nat Cell Biol 3: 573–579.
51. DerkatchIL, UptainSM, OuteiroTF, KrishnanR, LindquistSL, et al. (2004) Effects of Q/N-rich, polyQ, and non-polyQ amyloids on the de novo formation of the [PSI+] prion in yeast and aggregation of Sup35 in vitro. Proc Natl Acad Sci U S A 101: 12934–12939.
52. KrammerC, KryndushkinD, SuhreMH, KremmerE, HofmannA, et al. (2009) The yeast Sup35NM domain propagates as a prion in mammalian cells. Proc Natl Acad Sci U S A 106: 462–467.
53. HabensteinB, BoussetL, SouriguesY, KabaniM, LoquetA, et al. (2012) A native-like conformation for the C-terminal domain of the prion Ure2p within its fibrillar form. Angew Chem Int Ed Engl 51: 7963–7966.
54. BoussetL, ThomsonNH, RadfordSE, MelkiR (2002) The yeast prion Ure2p retains its native alpha-helical conformation upon assembly into protein fibrils in vitro. EMBO J 21: 2903–2911.
55. GidalevitzT, Ben-ZviA, HoKH, BrignullHR, MorimotoRI (2006) Progressive disruption of cellular protein folding in models of polyglutamine diseases. Science 311: 1471–1474.
56. Mohri-ShiomiA, GarsinDA (2008) Insulin signaling and the heat shock response modulate protein homeostasis in the Caenorhabditis elegans intestine during infection. J Biol Chem 283: 194–201.
57. FevrierB, ViletteD, ArcherF, LoewD, FaigleW, et al. (2004) Cells release prions in association with exosomes. Proc Natl Acad Sci U S A 101: 9683–9688.
58. GoussetK, SchiffE, LangevinC, MarijanovicZ, CaputoA, et al. (2009) Prions hijack tunnelling nanotubes for intercellular spread. Nat Cell Biol 11: 328–336.
59. GardenGA, La SpadaAR (2012) Intercellular (mis)communication in neurodegenerative disease. Neuron 73: 886–901.
60. ChiesaR, PiccardoP, GhettiB, HarrisDA (1998) Neurological illness in transgenic mice expressing a prion protein with an insertional mutation. Neuron 21: 1339–1351.
61. FlechsigE, ShmerlingD, HegyiI, RaeberAJ, FischerM, et al. (2000) Prion protein devoid of the octapeptide repeat region restores susceptibility to scrapie in PrP knockout mice. Neuron 27: 399–408.
62. McGlincheyRP, KryndushkinD, WicknerRB (2011) Suicidal [PSI+] is a lethal yeast prion. Proc Natl Acad Sci U S A 108: 5337–5341.
63. GarceaRL, SchachatF, EpsteinHF (1978) Coordinate synthesis of two myosins in wild-type and mutant nematode muscle during larval development. Cell 15: 421–428.
64. TapleyEC, LyN, StarrDA (2011) Multiple mechanisms actively target the SUN protein UNC-84 to the inner nuclear membrane. Mol Biol Cell 22: 1739–1752.
65. HaraT, NakamuraK, MatsuiM, YamamotoA, NakaharaY, et al. (2006) Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 441: 885–889.
66. KomatsuM, WaguriS, ChibaT, MurataS, IwataJ, et al. (2006) Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 441: 880–884.
67. LevineB, KroemerG (2009) Autophagy in aging, disease and death: the true identity of a cell death impostor. Cell Death Differ 16: 1–2.
68. Martinez-VicenteM, CuervoAM (2007) Autophagy and neurodegeneration: when the cleaning crew goes on strike. Lancet Neurol 6: 352–361.
69. HeisekeA, AguibY, SchatzlHM Autophagy, prion infection and their mutual interactions. Curr Issues Mol Biol 12: 87–97.
70. AguibY, HeisekeA, GilchS, RiemerC, BaierM, et al. (2009) Autophagy induction by trehalose counteracts cellular prion infection. Autophagy 5: 361–369.
71. HeisekeA, AguibY, RiemerC, BaierM, SchatzlHM (2009) Lithium induces clearance of protease resistant prion protein in prion-infected cells by induction of autophagy. J Neurochem 109: 25–34.
72. SpencerB, PotkarR, TrejoM, RockensteinE, PatrickC, et al. (2009) Beclin 1 gene transfer activates autophagy and ameliorates the neurodegenerative pathology in alpha-synuclein models of Parkinson's and Lewy body diseases. J Neurosci 29: 13578–13588.
73. KrugerU, WangY, KumarS, MandelkowEM (2011) Autophagic degradation of tau in primary neurons and its enhancement by trehalose. Neurobiol Aging
74. SchaefferV, LavenirI, OzcelikS, TolnayM, WinklerDT, et al. (2012) Stimulation of autophagy reduces neurodegeneration in a mouse model of human tauopathy. Brain
75. ChenSF, KangML, ChenYC, TangHW, HuangCW, et al. (2012) Autophagy-related gene 7 is downstream of heat shock protein 27 in the regulation of eye morphology, polyglutamine toxicity, and lifespan in Drosophila. J Biomed Sci 19: 52.
76. LeeJA, GaoFB (2009) Inhibition of autophagy induction delays neuronal cell loss caused by dysfunctional ESCRT-III in frontotemporal dementia. J Neurosci 29: 8506–8511.
77. CharrouxB, FantoM (2010) The fine line between waste disposal and recycling: DRPLA fly models illustrate the importance of completing the autophagy cycle for rescuing neurodegeneration. Autophagy 6
78. LingD, SalvaterraPM (2011) Brain aging and Abeta(1)(-)(4)(2) neurotoxicity converge via deterioration in autophagy-lysosomal system: a conditional Drosophila model linking Alzheimer's neurodegeneration with aging. Acta Neuropathol 121: 183–191.
79. DehayB, BoveJ, Rodriguez-MuelaN, PerierC, RecasensA, et al. (2010) Pathogenic lysosomal depletion in Parkinson's disease. J Neurosci 30: 12535–12544.
80. Bossy-WetzelE, BarsoumMJ, GodzikA, SchwarzenbacherR, LiptonSA (2003) Mitochondrial fission in apoptosis, neurodegeneration and aging. Curr Opin Cell Biol 15: 706–716.
81. SettembreC, FraldiA, JahreissL, SpampanatoC, VenturiC, et al. (2008) A block of autophagy in lysosomal storage disorders. Hum Mol Genet 17: 119–129.
82. SettembreC, FraldiA, RubinszteinDC, BallabioA (2008) Lysosomal storage diseases as disorders of autophagy. Autophagy 4: 113–114.
83. de Pablo-LatorreR, SaideA, PolishhuckEV, NuscoE, FraldiA, et al. (2012) Impaired parkin-mediated mitochondrial targeting to autophagosomes differentially contributes to tissue pathology in lysosomal storage diseases. Hum Mol Genet 21: 1770–1781.
84. JaiswalJK, AndrewsNW, SimonSM (2002) Membrane proximal lysosomes are the major vesicles responsible for calcium-dependent exocytosis in nonsecretory cells. J Cell Biol 159: 625–635.
85. ReddyA, CalerEV, AndrewsNW (2001) Plasma membrane repair is mediated by Ca(2+)-regulated exocytosis of lysosomes. Cell 106: 157–169.
86. YasudaK, KhandareA, BurianovskyyL, MaruyamaS, ZhangF, et al. (2011) Tunneling nanotubes mediate rescue of prematurely senescent endothelial cells by endothelial progenitors: exchange of lysosomal pool. Aging (Albany NY) 3: 597–608.
87. TermanA, BrunkUT (1998) Ceroid/lipofuscin formation in cultured human fibroblasts: the role of oxidative stress and lysosomal proteolysis. Mech Ageing Dev 104: 277–291.
88. KrammerC, SuhreMH, KremmerE, DiemerC, HessS, et al. (2008) Prion protein/protein interactions: fusion with yeast Sup35p-NM modulates cytosolic PrP aggregation in mammalian cells. FASEB J 22: 762–773.
89. GarritySJ, SivanathanV, DongJ, LindquistS, HochschildA (2010) Conversion of a yeast prion protein to an infectious form in bacteria. Proc Natl Acad Sci U S A 107: 10596–10601.
90. DerkatchIL, BradleyME, HongJY, LiebmanSW (2001) Prions affect the appearance of other prions: the story of [PIN(+)]. Cell 106: 171–182.
91. DerkatchIL, BradleyME, ZhouP, ChernoffYO, LiebmanSW (1997) Genetic and environmental factors affecting the de novo appearance of the [PSI+] prion in Saccharomyces cerevisiae. Genetics 147: 507–519.
92. OsherovichLZ, WeissmanJS (2001) Multiple Gln/Asn-rich prion domains confer susceptibility to induction of the yeast [PSI(+)] prion. Cell 106: 183–194.
93. MichelitschMD, WeissmanJS (2000) A census of glutamine/asparagine-rich regions: implications for their conserved function and the prediction of novel prions. Proc Natl Acad Sci U S A 97: 11910–11915.
94. ChenB, BruceKL, NewnamGP, GyonevaS, RomanyukAV, et al. (2010) Genetic and epigenetic control of the efficiency and fidelity of cross-species prion transmission. Mol Microbiol 76: 1483–1499.
95. ChienP, DePaceAH, CollinsSR, WeissmanJS (2003) Generation of prion transmission barriers by mutational control of amyloid conformations. Nature 424: 948–951.
96. FireA, HarrisonSW, DixonD (1990) A modular set of lacZ fusion vectors for studying gene expression in Caenorhabditis elegans. Gene 93: 189–198.
97. BrennerS (1974) The genetics of Caenorhabditis elegans. Genetics 77: 71–94.
98. KrzewskaJ, TanakaM, BurstonSG, MelkiR (2007) Biochemical and functional analysis of the assembly of full-length Sup35p and its prion-forming domain. J Biol Chem 282: 1679–1686.
99. WalshDM, ThulinE, MinogueAM, GustavssonN, PangE, et al. (2009) A facile method for expression and purification of the Alzheimer's disease-associated amyloid beta-peptide. FEBS J 276: 1266–1281.
100. ThualC, KomarAA, BoussetL, Fernandez-BellotE, CullinC, et al. (1999) Structural characterization of Saccharomyces cerevisiae prion-like protein Ure2. J Biol Chem 274: 13666–13674.